Intelligent neuro-orthosis could benefit patients with limited hand function

A sub­ur­ban Chica­go man who used in­sid­er in­for­ma­tion he got from his spouse, who worked at Ar­ray Bio­Phar­ma, to make near­ly $100,000 from buy­ing and

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

Ver­tex said it made $2 mil­lion in rev­enue from the first pa­tient who re­ceived its sick­le cell ther­a­py Cas­gevy. The com­mer­cial launch­es of Cas­gevy and